High Point Advisor Group LLC Abbott Laboratories Transaction History

High Point Advisor Group LLC

$1.67 Billion
Q3 2024

A detailed history of High Point Advisor Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, High Point Advisor Group LLC holds 162,410 shares of ABT stock, worth $18.3 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares

162,410

Previous 179,586 9.56%

Holding current value

$18.3 Million

Previous $18.7 Million 0.77%

% of portfolio

1.11%

Previous 1.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$100.07 - $118.13 $1.72 Million - $2.03 Million	-17,176 Reduced 9.56%	162,410 $18.5 Million
Q2 2024 Aug 08, 2024	BUY	$100.73 - $112.44 $4.2 Million - $4.69 Million	41,710 Added 30.25%	179,586 $18.7 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $86,520 - $95,558	-790 Reduced 0.57%	137,876 $15.7 Million
Q4 2023 Mar 26, 2024	SELL	$90.19 - $110.4 $109,941 - $134,577	-1,219 Reduced 0.87%	138,666 $15.3 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $156,167 - $188,756	1,530 Added 1.11%	139,885 $15.2 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $84,928 - $93,955	-728 Reduced 0.52%	138,355 $16.3 Million
Q2 2021 Jul 29, 2021	BUY	$105.79 - $124.53 $311,022 - $366,118	2,940 Added 2.16%	139,083 $16.1 Million
Q1 2021 Apr 12, 2021	SELL	$108.84 - $128.23 $2.3 Million - $2.71 Million	-21,170 Reduced 13.46%	136,143 $16.5 Million
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $7.92 Million - $8.63 Million	75,394 Added 92.03%	157,313 $19.7 Million
Q3 2020 Nov 06, 2020	BUY	$91.64 - $111.29 $534,536 - $649,154	5,833 Added 7.67%	81,919 $9.3 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $15,313 - $19,600	200 Added 0.26%	76,086 $6.97 Million
Q1 2020 May 01, 2020	BUY	$62.82 - $91.86 $4.32 Million - $6.32 Million	68,749 Added 963.28%	75,886 $7.14 Million
Q1 2020 Apr 27, 2020	SELL	$62.82 - $91.86 $4.23 Million - $6.19 Million	-67,396 Reduced 90.42%	7,137 $75.9 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $504,819 - $561,982	6,430 Added 9.44%	74,533 $6.69 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $491,694 - $533,149	6,008 Added 9.68%	68,103 $5.7 Million
Q2 2019 Aug 15, 2019	BUY	$72.88 - $85.0 $55,024 - $64,175	755 Added 1.23%	62,095 $5.47 Million
Q1 2019 May 08, 2019	BUY	$66.22 - $80.06 $250,444 - $302,786	3,782 Added 6.57%	61,340 $4.72 Million
Q4 2018 Feb 20, 2019	BUY	$65.56 - $74.27 $30,550 - $34,609	466 Added 0.82%	57,558 $4.32 Million
Q3 2018 Oct 24, 2018	SELL	$60.81 - $73.36 $37,033 - $44,676	-609 Reduced 1.06%	57,092 $3.91 Million
Q2 2018 Aug 20, 2018	SELL	$57.57 - $63.54 $40,701 - $44,922	-707 Reduced 1.21%	57,701 $3.7 Million
Q1 2018 Jun 11, 2018	SELL	$56.27 - $63.62 $35,731 - $40,398	-635 Reduced 1.08%	58,408 $3.7 Million
Q4 2017 Feb 15, 2018	BUY	$53.68 - $57.47 $35,375 - $37,872	659 Added 1.13%	59,043 $3.4 Million
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $2.81 Million - $3.13 Million	58,384	58,384 $3.17 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.

Account

High Point Advisor Group LLC Abbott Laboratories Transaction History